Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

New Insights on the Nutrition Status and Antioxidant Capacity in Multiple Sclerosis Patients.

Armon-Omer A, Waldman C, Simaan N, Neuman H, Tamir S, Shahien R.

Nutrients. 2019 Feb 18;11(2). pii: E427. doi: 10.3390/nu11020427.

2.

Atypical development of neurosyphilis mimicking limbic encephalitis.

Beiruti K, Abu Awad A, Keigler G, Ryder CH, Shahien R.

Int J STD AIDS. 2019 Feb;30(2):194-197. doi: 10.1177/0956462418797873. Epub 2018 Sep 26.

PMID:
30253732
3.

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.

Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS; ORATORIO Clinical Investigators.

N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.

4.

Effects of delayed-release dimethyl fumarate on MRI measures in the phase 3 CONFIRM study.

Miller DH, Fox RJ, Phillips JT, Hutchinson M, Havrdova E, Kita M, Wheeler-Kingshott CA, Tozer DJ, MacManus DG, Yousry TA, Goodsell M, Yang M, Zhang R, Viglietta V, Dawson KT; CONFIRM study investigators.

Neurology. 2015 Mar 17;84(11):1145-52. doi: 10.1212/WNL.0000000000001360. Epub 2015 Feb 13.

5.

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.

Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, Viglietta V, Dawson KT; CONFIRM Study Investigators.

N Engl J Med. 2012 Sep 20;367(12):1087-97. Erratum in: N Engl J Med. 2012 Oct 25;367(17):1673.

6.

Multiple sclerosis in diverse populations: characteristics in distinct Arab ethnicities in Israel.

Siegel M, Paperna T, Lejbkowicz I, Petrou P, Shahien R, Karussis D, Lavi I, Dishon S, Rawashdeh H, Miller A.

Mult Scler. 2012 Dec;18(12):1737-44. doi: 10.1177/1352458512445059. Epub 2012 May 8.

PMID:
22570361
7.

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy in an Israeli family.

Shahien R, Bianchi S, Bowirrat A.

Neuropsychiatr Dis Treat. 2011;7:383-90. doi: 10.2147/NDT.S19399. Epub 2011 Jun 20.

8.

Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability.

Bowirrat A, Chen TJ, Blum K, Madigan M, Bailey JA, Chuan Chen AL, Downs BW, Braverman ER, Radi S, Waite RL, Kerner M, Giordano J, Morse S, Oscar-Berman M, Gold M.

Curr Neuropharmacol. 2010 Dec;8(4):335-58. doi: 10.2174/157015910793358123.

9.
10.

Amoxicillin-induced aseptic meningoencephalitis.

Shahien R, Vieksler V, Bowirrat A.

Int J Gen Med. 2010 Jul 21;3:157-62.

11.

Neuro-Beh├žet's disease: a report of sixteen patients.

Shahien R, Bowirrat A.

Neuropsychiatr Dis Treat. 2010 May 25;6:219-25.

Supplemental Content

Loading ...
Support Center